Patent details
EP3632907 Title: N-(AZAARYL)CYCLOLACTAM-1-CARBOXAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
Basic Information
- Publication number:
- EP3632907
- PCT Application Number:
- CN2018087807
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP188052880
- PCT Publication Number:
- WO2018214867
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- N-(AZAARYL)CYCLOLACTAM-1-CARBOXAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
- French Title of Invention:
- DÉRIVÉ DE N-(AZAARYL)CYCLOLACTAME-1-CARBOXAMIDE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
- German Title of Invention:
- N-(AZAARYL) CYCLOLACTAM-1-CARBOXAMID-DERIVAT, HERSTELLUNGSVERFAHREN DAFÜR UND VERWENDUNG DAVON
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 13/03/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 21/03/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 28/02/2024
- Unitary Effect Registration Date:
- 21/03/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 22/05/2018
- Grant date:
- 28/02/2024
- EP Publication Date:
- 08/04/2020
- PCT Publication Date:
- 29/11/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/02/2024
- EP B1 Publication Date:
- 28/02/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 22/05/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/02/2024
- Name:
- Abbisko Therapeutics Co., Ltd.
- Address:
- No. 3, Lane 898, HaLei Road China (Shanghai) Pilot Free Trade Zone Pudong New Area, Shanghai 201203, China (CN)
Inventor
1
- Name:
- XU, Yaochang
- Address:
- China (CN)
2
- Name:
- ZHANG, Mingming
- Address:
- China (CN)
3
- Name:
- YU, Hongping
- Address:
- China (CN)
4
- Name:
- YANG, Shuqun
- Address:
- China (CN)
5
- Name:
- ZHAO, Baowei
- Address:
- China (CN)
6
- Name:
- CHEN, Zhui
- Address:
- China (CN)
Priority
- Priority Number:
- 201710378071
- Priority Date:
- 24/05/2017
- Priority Country:
- China (CN)
Classification
- IPC classification:
- C07D 401/14; C07D 413/14; C07D 417/14; A61K 31/4439; A61K 31/497; A61P 35/00; A61P 37/00; A61P 3/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202409
- Publication date:
- 28/02/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202416
- Publication date:
- 17/04/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202417
- Publication date:
- 24/04/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|